FDA Drug recall D-0356-2021
Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc
- FDA Drug
- Class II
- ongoing
- Published 2021-04-28
On 2021-04-28 the FDA classified a Class II recall of Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc by Teligent Pharma, citing failed Impurities/Degradation Specifications:.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0356-2021 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2021-04-09 |
| Published | 2021-04-28 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teligent Pharma |
| Distribution | US |
Product
Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60
Reason
Failed Impurities/Degradation Specifications:
Identifiers
| code_info | Lot #13974 EXP 7/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0356-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.